| UTS2R |
UTS2R, GPR14: Urotensin II receptor |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
0.265 |
Evidence |
|
| UTS2R |
UTS2R, GPR14: Urotensin II receptor |
GNAI2 |
Galphai2 protein |
0.265 |
Evidence |
|
| OR12D3 |
OR12D3: Olfactory receptor 12D3 |
GNAI2 |
Galphai2 protein |
0.265 |
Evidence |
|
| MTRR |
MTRR: Methionine synthase reductase, mitochondrial precursor |
CYP21A2 |
CYP21A2, CYP21, CYP21B: Cytochrome P450 21 |
0.265 |
Evidence |
|
| MTRR |
MTRR: Methionine synthase reductase, mitochondrial precursor |
CYP46A1 |
CYP46A1, CYP46: Cytochrome P450 46A1 |
0.265 |
Evidence |
|
| MTRR |
MTRR: Methionine synthase reductase, mitochondrial precursor |
CYP8B1 |
CYP8B1, CYP12: Cytochrome P450 8B1 |
0.265 |
Evidence |
|
| ZNF446 |
ZNF446, ZKSCAN20: Zinc finger protein 446 |
ZNF132 |
ZNF132: Zinc finger protein 132 |
0.265 |
Evidence |
|
| ZNF446 |
ZNF446, ZKSCAN20: Zinc finger protein 446 |
ZNF615 |
DKFZp686O1554: Putative uncharacterized protein DKFZp686O1554 |
0.265 |
Evidence |
|
| ZNF446 |
ZNF446, ZKSCAN20: Zinc finger protein 446 |
ZNF214 |
ZNF214, BAZ1: Zinc finger protein 214 |
0.265 |
Evidence |
|
| TNFRSF19 |
TNFRSF19, TAJ, UNQ1888/PRO4333, TROY: Tumor necrosis factor receptor superfamily |
TNFSF18 |
TNFSF18, AITRL, UNQ149/PRO175, GITRL, TL6: Tumor necrosis factor ligand superfam |
0.265 |
Evidence |
|
| GPR27 |
GPR27, SREB1: Probable G-protein coupled receptor 27 |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
0.265 |
Evidence |
|
| GPR27 |
GPR27, SREB1: Probable G-protein coupled receptor 27 |
GNAI2 |
Galphai2 protein |
0.265 |
Evidence |
|
| KCNH7 |
KCNH7, ERG3: Potassium voltage-gated channel subfamily H member 7 |
CNGB1 |
RCNC2: Rod photoreceptor CNG-channel beta subunit |
0.265 |
Evidence |
|
| KCNH7 |
KCNH7, ERG3: Potassium voltage-gated channel subfamily H member 7 |
KCNQ5 |
IPI00396336 |
0.265 |
Evidence |
|
| KCNH7 |
KCNH7, ERG3: Potassium voltage-gated channel subfamily H member 7 |
SCN5A |
SCN5A: Sodium channel protein type 5 subunit alpha |
0.265 |
Evidence |
|
| KCNH7 |
KCNH7, ERG3: Potassium voltage-gated channel subfamily H member 7 |
TRPV1 |
TRPV1: Vanilloid receptor variant TRPV1b |
0.265 |
Evidence |
|
| KCNH7 |
KCNH7, ERG3: Potassium voltage-gated channel subfamily H member 7 |
SCN10A |
SCN10A, PN3: Sodium channel protein type 10 subunit alpha |
0.265 |
Evidence |
|
| KCNH7 |
KCNH7, ERG3: Potassium voltage-gated channel subfamily H member 7 |
TRPV2 |
TRPV2: Uncharacterized protein TRPV2 |
0.265 |
Evidence |
|
| KCNH7 |
KCNH7, ERG3: Potassium voltage-gated channel subfamily H member 7 |
KCNH4 |
KCNH4: Potassium voltage-gated channel subfamily H member 4 |
0.265 |
Evidence |
|
| KCNH7 |
KCNH7, ERG3: Potassium voltage-gated channel subfamily H member 7 |
KCNH3 |
KCNH3, KIAA1282: Potassium voltage-gated channel subfamily H member 3 |
0.265 |
Evidence |
|
| TMPRSS4 |
TMPRSS4, TMPRSS3, UNQ776/PRO1570: Transmembrane protease, serine 4 |
PLXNC1 |
PLXNC1, VESPR: Plexin-C1 precursor |
0.265 |
Evidence |
|
| CYP4F12 |
CYP4F12, UNQ568/PRO1129: Cytochrome P450 4F12 |
MTRR |
MTRR: Methionine synthase reductase, mitochondrial precursor |
0.265 |
Evidence |
|
| ARNT2 |
ARNT2, KIAA0307: Aryl hydrocarbon receptor nuclear translocator 2 |
HES4 |
HES4: Transcription factor HES-4 |
0.265 |
Evidence |
|
| EDA2R |
EDA2R, TNFRSF27, UNQ2448/PRO34080/PRO5727, XEDAR: Tumor necrosis factor receptor |
TNFSF13B |
TNFSF13B, BAFF, UNQ401/PRO738, BLYS, TALL1, TNFSF20, ZTNF4: Tumor necrosis facto |
0.265 |
Evidence |
|
| GNB4 |
GNB4: Guanine nucleotide-binding protein subunit beta-4 |
RGS6 |
IPI00719243 |
0.265 |
Evidence |
|